Evaluation of Accuracy of Rapid Tests for Group A Beta Hemolytic Streptococci in Out-patients With Sore Throat
Primary Purpose
Pharyngitis
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Sofia
QuickVue
Throat swab culture
Sponsored by
About this trial
This is an interventional diagnostic trial for Pharyngitis
Eligibility Criteria
Inclusion Criteria:
- Patients who came with sore throat less than 5 days.
Exclusion Criteria:
- No
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
Experimental
Arm Label
Sofia
QuickVue
Throat swab culture
Arm Description
Patients who presented with sore throat will be performed throat swab and sent for Sofia which is rapid test.
Patients who presented with sore throat will be performed throat swab and sent for QuickVue which is rapid test.
Patients who presented with sore throat will be performed throat swab and sent for throat swab culture which is gold standard.
Outcomes
Primary Outcome Measures
Of participants positive for Group A Streptococcus by Sofia rapid test, the percentage who are positive for Group A Streptococcus by Sofia rapid test.
Establish sensitivity against a gold standard. Report as a percentage of participants with 95% confidence limits.
Of participants positive for Group A Streptococcus by Sofia rapid test, the percentage who are negative for Group A Streptococcus by Sofia rapid test.
Establish specificity against a gold standard. Report as a percentage of participants with 95% confidence limits.
Of participants positive for Group A Streptococcus by QuickVue rapid test, the percentage who are positive for Group A Streptococcus by QuickVue rapid test.
Establish sensitivity against a gold standard. Report as a percentage of participants with 95% confidence limits.
Of participants positive for Group A Streptococcus by QuickVue rapid test, the percentage who are negative for Group A Streptococcus by QuickVue rapid test.
Establish specificity against a gold standard. Report as a percentage of participants with 95% confidence limits.
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02623985
Brief Title
Evaluation of Accuracy of Rapid Tests for Group A Beta Hemolytic Streptococci in Out-patients With Sore Throat
Official Title
Evaluation of Accuracy of Rapid Tests for Group A Beta Hemolytic Streptococci in Out-patients With Sore Throat From Acute Pharyngitis at Siriraj Hospital
Study Type
Interventional
2. Study Status
Record Verification Date
October 2022
Overall Recruitment Status
Completed
Study Start Date
December 2015 (Actual)
Primary Completion Date
December 2016 (Actual)
Study Completion Date
June 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mahidol University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to evaluate accuracy of rapid tests for group A beta hemolytic streptococci in patients who presented with sore throat at out patient department in Siriraj Hospital.
Detailed Description
The patients who presented with sore throat at out patient department less than 5 days and age over 6 years old would be enrolled by the primary physicians and the consent forms will be completed by researcher.
The throat swab would be performed by using Sofia, QuickVue rapid tests compare to the gold standard which is a throat swab culture to evaluate the accuracy of the rapid tests.
The sample size for validation of sensitivity and specificity of rapid tests is 358 patients.
The primary outcome is will be evaluated sensitivity and specificity of both rapid tests.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pharyngitis
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
360 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Sofia
Arm Type
Experimental
Arm Description
Patients who presented with sore throat will be performed throat swab and sent for Sofia which is rapid test.
Arm Title
QuickVue
Arm Type
Experimental
Arm Description
Patients who presented with sore throat will be performed throat swab and sent for QuickVue which is rapid test.
Arm Title
Throat swab culture
Arm Type
Experimental
Arm Description
Patients who presented with sore throat will be performed throat swab and sent for throat swab culture which is gold standard.
Intervention Type
Device
Intervention Name(s)
Sofia
Other Intervention Name(s)
Sofia for rapid test
Intervention Description
Patients who presented with sore throat will be performed throat swab and sent for Sofia for rapid test.
Intervention Type
Device
Intervention Name(s)
QuickVue
Other Intervention Name(s)
QuickVue for rapid test
Intervention Description
Patients who presented with sore throat will be performed throat swab and sent for QuickVue for rapid test.
Intervention Type
Device
Intervention Name(s)
Throat swab culture
Other Intervention Name(s)
throat swab culture for gold standard
Intervention Description
Patients who presented with sore throat will be performed throat swab and sent for throat swab culture for gold standard.
Primary Outcome Measure Information:
Title
Of participants positive for Group A Streptococcus by Sofia rapid test, the percentage who are positive for Group A Streptococcus by Sofia rapid test.
Description
Establish sensitivity against a gold standard. Report as a percentage of participants with 95% confidence limits.
Time Frame
Day 1
Title
Of participants positive for Group A Streptococcus by Sofia rapid test, the percentage who are negative for Group A Streptococcus by Sofia rapid test.
Description
Establish specificity against a gold standard. Report as a percentage of participants with 95% confidence limits.
Time Frame
Day 1
Title
Of participants positive for Group A Streptococcus by QuickVue rapid test, the percentage who are positive for Group A Streptococcus by QuickVue rapid test.
Description
Establish sensitivity against a gold standard. Report as a percentage of participants with 95% confidence limits.
Time Frame
Day 1
Title
Of participants positive for Group A Streptococcus by QuickVue rapid test, the percentage who are negative for Group A Streptococcus by QuickVue rapid test.
Description
Establish specificity against a gold standard. Report as a percentage of participants with 95% confidence limits.
Time Frame
Day 1
10. Eligibility
Sex
All
Minimum Age & Unit of Time
7 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients who came with sore throat less than 5 days.
Exclusion Criteria:
No
12. IPD Sharing Statement
Citations:
PubMed Identifier
26159722
Citation
Plainvert C, Duquesne I, Touak G, Dmytruk N, Poyart C. In vitro evaluation and comparison of 5 rapid antigen detection tests for the diagnosis of beta-hemolytic group A streptococcal pharyngitis. Diagn Microbiol Infect Dis. 2015 Oct;83(2):105-11. doi: 10.1016/j.diagmicrobio.2015.06.012. Epub 2015 Jun 23.
Results Reference
background
Learn more about this trial
Evaluation of Accuracy of Rapid Tests for Group A Beta Hemolytic Streptococci in Out-patients With Sore Throat
We'll reach out to this number within 24 hrs